Roger was appointed Chief Executive at The Christie in March 2015, having previously worked as Interim Chief Executive and Chief Operating Officer.
Roger has managed significant service developments including satellite radiotherapy & chemotherapy centres across Greater Manchester, transforming delivery of Christie services to an outpatient model. He directed the establishment of Christie partnerships for pharmacy, pathology, specialist diagnostic services and private patients & our academic investment plan. Roger leads for Greater Manchester in the National Cancer Vanguard developing & testing new models of care. In 2016 Roger led the Trust to a CQC Outstanding rating and is in the top 15 chief executives ranked by the HSJ in 2017. Roger leads the Christie in delivering the first national Proton Therapy service in the UK, operational in 2018.
Roger holds an MBA, an honours degree in Nursing Studies, is a Registered Nurse and is an independent director of Southway Housing Trust.
Roger previously worked at Salford Royal, East Lancashire Hospitals & Greater Manchester SHA.